Clontech
login | register | order now | view cart | feedback
Products
Cell Biology & Epigenetics
Alzheimers Disease
Apoptosis Kits and Reagents
Bone Research
Brain and CNS
Cancer and Inflammation
Cell Adhesion and Extracellular Matrix
Cell Proliferation and Viability
Cytokines
Environmental Hazards
Epigenetics
Metabolic Diseases
Miscellaneous
mTOR Signaling
RNA Interference
Signal Transduction
Virus Research


Products >  Cell_Biology_and_Epigenetics >  Cancer_and_Inflammation >  IDH1

Anti-Human IDH1 Mouse IgG MoAb

Isocitrate dehydrogenases (IDH) catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate, and are divided into NAD(+)-dependent and NADP(+)-dependent classes. Five isocitrate dehydrogenases are currently known. The enzyme encoded by the IDH1 gene in humans is a NADP(+)-dependent isocitrate dehydrogenase found in the cytoplasm and peroxisomes. The IDH1 gene product has been suggested to function in the regeneration of NADPH for intraperoxisomal reduction reactions, and in peroxisomal reactions that consume 2-oxoglutarate. Mutations in the IDH1 gene have been reported in several brain tumors including astrocytoma, oligodendroglioma, glioblastoma multiforme, and secondary glioblastomas. IDH1 is also known as isocitrate dehydrogenase 1 (NADP+), soluble; isocitrate dehydrogenase [NADP] cytoplasmic; NADP-dependent isocitrate dehydrogenase, cytosolic; NADP-dependent isocitrate dehydrogenase, peroxisomal; IDH, IDP, IDCD, IDPC, and PICD.

These products are affinity-purified IgG antibodies that recognize the R132H (Cat.# 10389) and R132S (Cat.# 10391) mutations of human IDH1. The antibodies were raised in mouse using synthetic peptides, and can be used for Western blot (WB) detection or immunohistochemical (IHC) detection of human IDH1 mutants.
  At-A-Glance   Documents   Images & Data

Features

  • Cat.#: 10389A, 10389B
  • Target Name: Human IDH1 (R132H mutant)
  • Antigen: Human IDH1 (R132H mutant) synthetic peptide
  • Specificity: Does not cross-react with human wild-type IDH1 or other IDH1 mutants
  • Application: WB, IHC
  • Target Entrez Gene ID: 3417

  • Cat.#: 10391A, 10391B
  • Target Name: Human IDH1 (R132S mutant)
  • Antigen: Human IDH1 (R132S mutant) synthetic peptide
  • Specificity: Does not cross-react with human wild-type IDH1 or other IDH1 mutants
  • Application: WB, IHC
  • Target Entrez Gene ID: 3417

Applications

Recommended antibody concentration (the optimal concentration should be determined empirically):

  • Western blot: 1–5 µg/mL
  • Immunohistochemical techniques: 5 µg/mL

Storage

Lyophilized: stable 5 years at 2–8°C. In solution: stable 2 years at –20°C.

Form

Lyophilized from an antibody solution containing 1% BSA in PBS and 0.05% NaN3. To use, reconstitute in 1.0 mL H2O (final concentration 100 µg/mL).

Alternative names

Isocitrate dehydrogenase 1 (NADP+), soluble; isocitrate dehydrogenase [NADP] cytoplasmic; NADP-dependent isocitrate dehydrogenase, cytosolic; NADP-dependent isocitrate dehydrogenase, peroxisomal; IDH, IDP, IDCD, IDPC, PICD
 
 
Products
Cat. # Product Contents Size Price Units Select
10389A Anti-Human IDH1 R132H (HMab-1) Mouse IgG MoAb 10 ug $121.00
10389B Anti-Human IDH1 R132H (HMab-1) Mouse IgG MoAb 100 ug $529.00
10391A Anti-Human IDH1 R132S (SMab-1) Mouse IgG MoAb 10 ug $121.00
10391B Anti-Human IDH1 R132S (SMab-1) Mouse IgG MoAb 100 ug $529.00
 

 

 
 

Takara Bio USA is a Takara Bio Company © 2017 Privacy Policy | Terms & Conditions | Terms of Use